Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 07, 2025 02:30 ET | Source: Yaqrit

Yaqrit’s HE candidates set for phase 3 as company shows underpinning data at EASL

Yaqrit presents phase 2a data at EASL on oral HE prevention treatment; and an improved HE patient staging tool approved for use by FDA in HE phase 3